Analysis of cost minimization of monotherapy antiepileptic treatment in patients with recent diagnosed epilepsy : the situation in Spain;Análisis de coste-minimización del tratamiento antiepiléptico en monoterapia en pacientes con epilepsia de reciente diagnóstico: situación en España.

Revista de neurologia

Volumn 31, Issue 9, 2000, Pages 828-832

  Arroyo, S ^a   Fossas, P ^a   Nieto Barrera, M ^a   Salas Puig, X ^a   Sanchez Alvarez J C ^a   Serratosa, J M ^a   Soler Singla, L ^a   Heaney, D C ^a   Sander, J W ^a   Shorvon, S ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; TRIAZINE DERIVATIVE; VALPROIC ACID;

CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; EPILEPSY; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY AND SPECIFICITY; SPAIN;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD; COST-BENEFIT ANALYSIS; EPILEPSY; HUMANS; PHENYTOIN; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SPAIN; TRIAZINES; VALPROIC ACID;

EID: 0034323469     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3109.2000356     Document Type: Review

References (17)